FDA 483 - Cetro America Inc. - January 11, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Cetrix America in Wallingford, CT, a specifications developer and initial importer, revealed a significant lack of established quality system procedures. The firm was cited for not having written procedures for the establishment and maintenance of a quality system, including a quality manual and procedures for corrective and preventive actions, complaint handling, and servicing. This indicates a fundamental deficiency in the firm's quality management system.
ID · 40797fe8-5154-4c8c-bf7e-236f3609c5ad